Inhibition of the mevalonate pathway potentiates the effects of lenalidomide in myeloma.

Files

Access status: Embargo until 2050-01-01 , AB Leukema Research Jan2009.pdf (814.85 KB)

Publication date

2009

Authors

van der Spek, E.
Bloem, Andries C.ISNI 0000000391313100
Lokhorst, Henk
van Kessel, B.
Bogers - Boer, L.H.
van de Donk, N.W.C.J.

Editors

Advisors

Supervisors

DOI

Document Type

Article

License

Abstract

Keywords

Citation

van der Spek, E, Bloem, A C, Lokhorst, H M, van Kessel, B, Bogers - Boer, L H & van de Donk, N W C J 2009, 'Inhibition of the mevalonate pathway potentiates the effects of lenalidomide in myeloma.', Leukemia Research, vol. 33, no. 1, pp. 100-108.